Medicare Enrolled
Florida Board Action on Record
The Florida Department of Health has flagged this practitioner's license with a board action.
Verify on FL DOH →
Dr. Craig Badolato, MD
Hematology & Oncology · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Badolato from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Badolato?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Badolato
Dr. Craig Badolato is a hematology & oncology specialist in Melbourne, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Badolato performed 15,449 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Badolato received a total of $40,821 from 116 pharmaceutical and/or device companies across 1726 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Badolato is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 24% volume in FL
$40,821 industry payments
Florida License Status
FL DOH · MQA1
Active license
Yes
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 61815 | Clear | January 31, 2028 | ⚠ |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗15,449
Medicare services
Top 24% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 9,720 | $18 | $70 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,582 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
892 | $8 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
729 | $8 | $19 |
| Anti-nausea injection (Aloxi/palonosetron) | 700 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
671 | $95 | $224 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
291 | $97 | $686 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
287 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
233 | $22 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
103 | $49 | $304 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $125 | $420 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
47 | $21 | $156 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $66 | $180 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
35 | $2 | $19 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $106 | $297 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $140 | $420 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.3% high complexity
79.8% medium
15.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$40,821
Total received (2018-2024)
Avg $5,832/year across 7 years
Top 16% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
116
Companies
1,726
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,124
2023
$6,358
2022
$6,070
2021
$5,811
2020
$4,665
2019
$6,864
2018
$4,929
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$522
E.R. Squibb & Sons, L.L.C.
$456
PFIZER INC.
$371
Incyte Corporation
$357
Lilly USA, LLC
$295
Genmab U.S., Inc.
$290
Merck Sharp & Dohme LLC
$283
Janssen Biotech, Inc.
$278
GlaxoSmithKline, LLC.
$237
Novartis Pharmaceuticals Corporation
$230
Bayer Healthcare Pharmaceuticals Inc.
$229
Astellas Pharma US Inc
$218
ABBVIE INC.
$205
Celgene Corporation
$190
Blueprint Medicines Corporation
$157
GENZYME CORPORATION
$132
Alexion Pharmaceuticals, Inc.
$125
Amgen Inc.
$124
Eisai Inc.
$122
SOBI, INC
$121
Daiichi Sankyo Inc.
$118
Regeneron Healthcare Solutions, Inc.
$98
Mirati Therapeutics, Inc.
$70
BeiGene USA, Inc.
$69
SERVIER PHARMACEUTICALS LLC
$68
Takeda Pharmaceuticals U.S.A., Inc.
$61
Gilead Sciences, Inc.
$56
Genentech USA, Inc.
$51
Kite Pharma, Inc.
$48
Fennec Pharmaceuticals, Inc.
$45
Pharmacosmos Therapeutics Inc.
$44
JAZZ PHARMACEUTICALS INC.
$39
ADC Therapeutics America, Inc.
$31
Karyopharm Therapeutics Inc.
$27
Ipsen Biopharmaceuticals, Inc
$26
Dendreon Pharmaceuticals LLC
$25
Sumitomo Pharma America, Inc.
$25
EMD Serono, Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Acrotech Biopharma Inc.
$21
PharmaEssentia USA Corporation
$19
TerSera Therapeutics LLC
$19
Aveo Pharmaceuticals, Inc.
$18
SpringWorks Therapeutics, Inc.
$18
Stemline Therapeutics Inc.
$17
Biocon Biologics Inc
$17
Agios Pharmaceuticals, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Novocure Inc.
$16
ARRAY BIOPHARMA INC
$15
Amneal Pharmaceuticals LLC
$15
PUMA BIOTECHNOLOGY, INC.
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 22.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,760
Novartis Pharmaceuticals Corporation
$2,514
Incyte Corporation
$2,156
Janssen Biotech, Inc.
$2,072
PFIZER INC.
$2,053
E.R. Squibb & Sons, L.L.C.
$1,960
Genentech USA, Inc.
$1,761
Daiichi Sankyo Inc.
$1,170
Merck Sharp & Dohme Corporation
$1,073
Takeda Pharmaceuticals U.S.A., Inc.
$1,014
GENZYME CORPORATION
$981
Celgene Corporation
$980
Merck Sharp & Dohme LLC
$968
Amgen Inc.
$945
Seagen Inc.
$916
Lilly USA, LLC
$898
Astellas Pharma US Inc
$872
Regeneron Healthcare Solutions, Inc.
$767
Puma Biotechnology, Inc.
$719
Bayer HealthCare Pharmaceuticals Inc.
$714
GlaxoSmithKline, LLC.
$619
Eisai Inc.
$580
Ipsen Biopharmaceuticals, Inc
$566
Pharmacyclics LLC, An AbbVie Company
$466
TOLMAR Pharmaceuticals, Inc.
$453
Boehringer Ingelheim Pharmaceuticals, Inc.
$421
Taiho Oncology, Inc.
$385
Mirati Therapeutics, Inc.
$384
Novocure Inc.
$373
JAZZ PHARMACEUTICALS INC.
$353
Bayer Healthcare Pharmaceuticals Inc.
$353
Genmab U.S., Inc.
$317
BeiGene USA, Inc.
$297
G1 Therapeutics, Inc.
$266
Karyopharm Therapeutics Inc.
$265
EISAI INC.
$250
ABBVIE INC.
$228
Blueprint Medicines Corporation
$210
EMD Serono, Inc.
$201
Helsinn Therapeutics (U.S.), Inc.
$199
Kite Pharma, Inc.
$195
PUMA BIOTECHNOLOGY, INC.
$193
Janssen Scientific Affairs, LLC
$192
Gilead Sciences, Inc.
$184
TESARO, Inc.
$183
Alexion Pharmaceuticals, Inc.
$182
SOBI, INC
$173
Epizyme, Inc.,
$169
Pharmacosmos Therapeutics Inc.
$167
Myriad Genetic Laboratories, Inc.
$159
Advanced Accelerator Applications
$146
Clovis Oncology, Inc.
$145
Verastem, Inc.
$138
Exelixis Inc.
$137
Sumitomo Pharma America, Inc.
$135
Heron Therapeutics, Inc.
$134
Rigel Pharmaceuticals, Inc.
$121
Pharmacyclics LLC, an AbbVie Company
$120
ARRAY BIOPHARMA INC
$117
SERVIER PHARMACEUTICALS LLC
$112
Global Blood Therapeutics, Inc.
$108
TerSera Therapeutics LLC
$102
Dova Pharmaceuticals
$92
Foundation Medicine, Inc.
$83
ADC Therapeutics America, Inc.
$82
Dendreon Pharmaceuticals LLC
$80
Adaptive Biotechnologies Corporation
$77
AbbVie, Inc.
$77
Mylan Institutional Inc.
$75
PharmaEssentia USA Corporation
$72
Kyowa Kirin, Inc.
$65
Sun Pharmaceutical Industries Inc.
$60
MorphoSys, US Inc.
$51
EUSA Pharma (US) LLC
$50
Stemline Therapeutics Inc.
$50
Coherus Biosciences Inc.
$50
Deciphera Pharmaceuticals Inc.
$49
Servier Pharmaceuticals LLC
$47
Amneal Pharmaceuticals LLC
$47
AVEO Pharmaceuticals, Inc.
$46
Fennec Pharmaceuticals, Inc.
$45
AbbVie Inc.
$43
AMAG Pharmaceuticals, Inc.
$42
Myovant Sciences Inc.
$39
Emmaus Medical, Inc.
$38
Secura Bio, Inc.
$37
Aveo Pharmaceuticals, Inc.
$37
Organon LLC
$33
Agios Pharmaceuticals, Inc.
$32
Seattle Genetics, Inc.
$32
Janssen Pharmaceuticals, Inc
$31
CTI BioPharma Corp.
$29
Verity Pharmaceuticals Inc.
$29
Sysmex Inostics Inc
$28
Sobi, Inc
$25
Medtronic USA, Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Acrotech Biopharma Inc.
$21
INSYS Therapeutics Inc
$20
Acrotech Biopharma LLC
$20
MACROGENICS, INC.
$19
Nestle HealthCare Nutrition Inc.
$18
Partner Therapeutics, Inc.
$18
Apellis Pharmaceuticals, Inc.
$18
SpringWorks Therapeutics, Inc.
$18
Biocon Biologics Inc
$17
Acceleron Pharma, Inc.
$17
TAIHO ONCOLOGY, INC.
$17
Ferring Pharmaceuticals Inc.
$15
Midatech Pharma US Inc
$15
Sirtex Medical Inc
$15
Fortovia Therapeutics, Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Jazz Pharmaceuticals Inc.
$12
Octapharma USA, Inc.
$12
Aurobindo Pharma USA, Inc.
$11
Top 3 companies account for 20.6% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARESTON · FARXIGA · FARYDAK · FASENRA · FERAHEME · FIRMAGON · FOTIVDA · FOUNDATIONONE · FULPHILA · Fabhalta · Farydak · Fulphila · GAZYVA · GILOTRIF · Gelclair · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leqembi · Lonsurf · Lunsumio · Lutathera · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · Marqibo · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCREVUS · ODOMZO · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · Odomzo · Ogivri · Oncology · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · RYZNEUTA · Reblozyl · Revlimid · Rituxan · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNAGIS · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zoladex · clonoSEQ · myPath · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
12
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
HOLMES REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Badolato is a mixed practice specialist, with above-average Medicare volume (top 24% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Badolato experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Badolato performed 9,720 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Badolato receive payments from pharmaceutical companies?
Yes. Dr. Badolato received a total of $40,821 from 116 companies across 1,726 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Badolato's costs compare to other hematology & oncology specialists in Melbourne?
Dr. Badolato's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Badolato) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Melbourne
Browse hematology & oncology specialists in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology